Borrelia hermsii
Borrelia hermsii is a species of spirochete bacteria that is known to cause tick-borne relapsing fever (TBRF) in humans. It is named after its discoverer, Dr. Willy Herms, who first identified the bacterium in the early 20th century.
Taxonomy[edit]
Borrelia is a genus of bacteria in the Spirochaetes phylum. The genus contains over 20 recognized species, including Borrelia hermsii. The species is further classified into two genomic groups, I and II, based on genetic differences.
Morphology[edit]
Borrelia hermsii is a spirochete, meaning it has a spiral-shaped structure. It is a Gram-negative, aerobic bacterium with a flexible, helical body that allows it to move in a corkscrew-like manner.
Life Cycle[edit]
The life cycle of Borrelia hermsii involves two hosts: a mammalian host, such as a human, and a tick vector, specifically the Ornithodoros hermsi tick. The bacterium is transmitted to humans through the bite of an infected tick.
Pathogenesis[edit]
Once inside the human host, Borrelia hermsii can cause tick-borne relapsing fever. The bacterium evades the host's immune system by periodically changing its surface proteins in a process known as antigenic variation. This allows the bacterium to cause recurrent episodes of fever and other symptoms.
Diagnosis and Treatment[edit]
Diagnosis of Borrelia hermsii infection is typically based on clinical symptoms and confirmed by laboratory tests, such as polymerase chain reaction (PCR) or serology. Treatment usually involves antibiotics, such as doxycycline or penicillin.
Prevention[edit]
Prevention of Borrelia hermsii infection primarily involves avoiding exposure to ticks in endemic areas. This can be achieved through the use of insect repellents, wearing protective clothing, and checking for ticks after outdoor activities.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian